News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Genentech, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Bay
The Day In Review: FDA Pays $500 Million For Cancer Drug
August 28, 2006
·
1 min read
FDA
Herceptin Cancer Drug Wins Final British Go-Ahead
August 23, 2006
·
1 min read
Biotech Bay
Brits Reject Genentech, Inc., ImClone Systems Incorporated Drugs As Too Expensive
August 21, 2006
·
1 min read
Biotech Beach
Genentech, Inc. Signs Groundbreaking License
August 10, 2006
·
1 min read
Biotech Beach
The Day In Review: Centient Consulting Inc. Beats Estimates
July 12, 2006
·
1 min read
Biotech Beach
The Day In Review: Curis, Inc. And Genentech, Inc. Stop Cancer Trial
July 12, 2006
·
1 min read
Biotech Beach
The Day In Review: Genentech, Inc. Stops Avastin Trial
June 27, 2006
·
1 min read
Biotech Beach
The Day In Review: Sleep Drug Data From Conference
June 21, 2006
·
1 min read
Policy
Major Drug Company Blocks Cheap Blindness Cure To Market More Expensive One
June 19, 2006
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma
December 22, 2025
·
16 min read
Press Releases
Genentech Announces Agreement With U.S. Government
December 22, 2025
·
2 min read
Press Releases
Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
December 17, 2025
·
3 min read
Press Releases
Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need
December 17, 2025
·
6 min read
Press Releases
Genentech’s Giredestrant Reduced Risk of Invasive Disease Recurrence or Death by 30% in ER-positive Early-Stage Breast Cancer
December 11, 2025
·
7 min read
Press Releases
Roche’s giredestrant reduced risk of invasive disease recurrence or death by 30% in ER-positive early-stage breast cancer
December 10, 2025
·
13 min read
Press Releases
Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas
December 9, 2025
·
19 min read
Press Releases
KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate VET3-TGI in Combination with Atezolizumab (Tecentriq®) in Advanced Solid Tumors
November 20, 2025
·
2 min read
Press Releases
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma
November 19, 2025
·
8 min read
Press Releases
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
November 19, 2025
·
7 min read
